Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Oncocytic (Hürthle Cell) Carcinoma Invading the Innominate Vein: A Case Report.

Created on 31 Jul 2026

Authors

Elias Wassel, Harpreet Gill, Ashley Stading, Lawrence B Kong

Published in

Cureus. Volume 18. Issue 6. Pages e111763. Epub Jun 29, 2026.

Abstract

Oncocytic (Hürthle cell) carcinoma is a rare subtype of differentiated thyroid carcinoma associated with increased vascular invasion, distant metastasis, and reduced responsiveness to radioactive iodine (RAI) therapy compared with other thyroid malignancies. Direct invasion of major mediastinal vessels, including the brachiocephalic (innominate) vein, is exceedingly rare and presents significant diagnostic and operative challenges. We report the case of a 71-year-old male who presented with progressive dysphagia and an enlarging multinodular goiter. Initial fine-needle aspiration was benign; however, worsening compressive symptoms prompted left thyroid lobectomy, which demonstrated widely invasive oncocytic carcinoma with extensive angioinvasion (pT3a). Completion thyroidectomy with central neck dissection revealed tumor invasion of the left internal jugular and middle thyroid veins, requiring ligation. Despite adjuvant RAI therapy, serum thyroglobulin (Tg) levels progressively increased. Subsequent positron emission tomography and computed tomography demonstrated a fluorodeoxyglucose (FDG)-avid thrombus and associated venous aneurysm involving the left brachiocephalic vein. The patient underwent successful resection via trapdoor thoracotomy with en bloc excision of the involved venous segment. Pathology confirmed metastatic oncocytic carcinoma with negative margins. This case highlights the importance of vigilant biochemical surveillance, advanced imaging, and aggressive multidisciplinary management in selected patients with oncocytic thyroid carcinoma involving the great vessels.

PMID:
42534132
Bibliographic data and abstract were imported from PubMed on 31 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement